Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP807814.RAZGnTjBkntf1yt4qJHXspClTStf9l29Sw_VargxjRWX8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP807814.RAZGnTjBkntf1yt4qJHXspClTStf9l29Sw_VargxjRWX8130_assertion type Assertion NP807814.RAZGnTjBkntf1yt4qJHXspClTStf9l29Sw_VargxjRWX8130_head.
- NP807814.RAZGnTjBkntf1yt4qJHXspClTStf9l29Sw_VargxjRWX8130_assertion description "[Moreover, as few as 1,000 CD133(+) MRTK cells initiated tumor development in nonobese diabetic/severe combined immunodeficient mice by 21 days (60-100%) in all examined cell lines, although the same number of CD133(-) MRTK cells could not form tumors (0%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP807814.RAZGnTjBkntf1yt4qJHXspClTStf9l29Sw_VargxjRWX8130_provenance.
- NP807814.RAZGnTjBkntf1yt4qJHXspClTStf9l29Sw_VargxjRWX8130_assertion evidence source_evidence_literature NP807814.RAZGnTjBkntf1yt4qJHXspClTStf9l29Sw_VargxjRWX8130_provenance.
- NP807814.RAZGnTjBkntf1yt4qJHXspClTStf9l29Sw_VargxjRWX8130_assertion SIO_000772 19383826 NP807814.RAZGnTjBkntf1yt4qJHXspClTStf9l29Sw_VargxjRWX8130_provenance.
- NP807814.RAZGnTjBkntf1yt4qJHXspClTStf9l29Sw_VargxjRWX8130_assertion wasDerivedFrom befree-20150227 NP807814.RAZGnTjBkntf1yt4qJHXspClTStf9l29Sw_VargxjRWX8130_provenance.
- NP807814.RAZGnTjBkntf1yt4qJHXspClTStf9l29Sw_VargxjRWX8130_assertion wasGeneratedBy ECO_0000203 NP807814.RAZGnTjBkntf1yt4qJHXspClTStf9l29Sw_VargxjRWX8130_provenance.